Teva Earnings Send Shares to New Low Not Seen in Over a Decade
These quarterly numbers are another black eye for Teva Pharmaceutical, sending shares to a low not seen since 2002.
All Work
Chris Lange
Blue Apron Makes the Cut Despite Q3 Loss
Blue Apron reported mixed third-quarter financial results before the markets opened Thursday, but shares rose in early trading.
EA Earnings Not Enough for Investors
Electronic Arts Inc. (NASDAQ: EA) reported its fiscal second-quarter financial results after the markets closed on Tuesday. The company said that it had $0.66 in Non-GAAP earnings per share (EPS) and $1.18 billion in…
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a relatively positive day for the markets with all of the major U.S. exchanges posting a gain, if only a little. Crude oil started out negative but came on strong in the…
Will Electric Vehicles Drive Nickel Endlessly Higher?
Nickel sulphate is a key ingredient in the lithium-ion batteries that power electric vehicles, and analysts are predicting this commodity could prove to be very profitable.
Why Under Armour Analysts Are Ditching Targets and Staying Negative
After Under Armour reported its most recent results, shares collapsed to a multiyear low. This was the first quarter in which Under Armour did not post revenue growth—what the company is known for.
What to Look for in Facebook Earnings Wednesday
After seeing the stock’s incredible rally in 2017, it doesn’t seem like anything can stop Facebook, and it looks like analysts agree.
Can This FDA Approval Keep Lifting Geron?
Geron is one of the few biopharma winners on Tuesday, with the health care sector in general pushing slightly lower on the day.
Pfizer Earnings Not Enough for Investors
When Pfizer released its third-quarter earnings report before the markets opened on Tuesday, the results and guidance lived up to what analysts expected but weren't enough to placate investors.
FTS International Gears Up for IPO
Hydraulic fracturing services provider FTS International has amended its filing with the SEC regarding its initial public offering.
Why Under Armour’s Q3 Is Scaring Investors
It didn't seem like things could get worse after the year that Under Armour has suffered through so far, but here we are. What makes this report especially scary?
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a relatively negative day for the markets with all of the major U.S. exchanges pulling back. Crude oil started out flat but came on strong in the afternoon. The S&P 500 sectors…
What to Look For When Under Armour Reports Q3 Earnings
In the starting match against Nike, Under Armour has not just blinked, but the company practically fell asleep. Under Armour may be facing some tough choices ahead.
Why Neos Therapeutics Is Holding Out Against PDL BioPharma
In a decisive move, the Neos Therapeutics board of directors unanimously struck down an acquisition proposal from PDL BioPharma.
What to Expect When Pfizer Reports Earnings
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
Why Novartis Is Moving to Acquire Advanced Accelerator Applications
Advanced Accelerator Applications shares made a run early on Monday after it came public that Novartis plans to buy the company.
Endo International Wins Big on Preliminary Results
Endo International saw its shares make a solid gain to start off the week after the firm announced preliminary financial results for its third quarter.
Facebook, Alibaba and More Major Earnings to Look For This Week
The busiest earnings week of the season has come and gone, but there are still plenty more big names stepping into the spotlight this week.
Apple, Tesla and More Top Tech Earnings Coming This Week
24/7 Wall St. has put together a preview of Apple, Tesla, some of the larger tech-related companies that are reporting their quarterly results this week.
Top Biopharma Events Coming by the End of 2017
24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November and December.